1.Drug repurposing against coronavirus disease 2019 (COVID-19):A review
Lianxiang LUO ; Qin QIU ; Fangfang HUANG ; Kaifeng LIU ; Yongqi LAN ; Xiaoling LI ; Yuge HUANG ; Liao CUI ; Hui LUO
Journal of Pharmaceutical Analysis 2021;11(6):683-690
Since December 2019,severe acute respiratory syndrome coronavirus 2 has been found to be the culprit in the coronavirus disease 2019 (COVID-19),causing a global pandemic.Despite the existence of many vaccine programs,the number of confirmed cases and fatalities due to COVID-19 is still increasing.Furthermore,a number of variants have been reported.Because of the absence of approved anti-coronavirus drugs,the treatment and management of COVID-19 has become a global challenge.Under these circumstances,drug repurposing is an effective method to identify candidate drugs with a shorter cycle of clinical trials.Here,we summarize the current status of the application of drug repurposing in COVID-19,including drug repurposing based on virtual computer screening,network pharmacology,and bioactivity,which may be a beneficial COVID-19 treatment.
Result Analysis
Print
Save
E-mail